HBV感染小鼠模型的研究进展

王军; 黄豫晓; 沈燕; 梁姣; 刘学武; 李英辉; 赵亚

doi:10.3969/j.issn.1001-5256.2016.01.036

HBV感染小鼠模型的研究进展

DOI: 10.3969/j.issn.1001-5256.2016.01.036

第四军医大学基础部病原生物学教研室

基金项目:

国家自然科学基金(31172167)；

详细信息

中图分类号: R512.62;R-332
计量
- 文章访问数: 3106
- HTML全文浏览量: 19
- PDF下载量: 624
- 被引次数: 0
出版历程
- 收稿日期: 2015-05-04
- 出版日期: 2016-01-20

Research advances in mouse models of hepatitis B virus infection

Department of Pathogenic Biology,Forth Military Medical University

Research funding:

摘要

摘要: HBV由于其较强的种属特异性,目前尚缺乏理想的实验动物模型来阐明其具体的发病机制。目前有关HBV感染模型的研究大多集中在小鼠方面,并已取得了很大进展。综述了HBV转基因小鼠、HBV转染小鼠和人鼠嵌合肝脏HBV小鼠等模型的优缺点,提出合理使用这些模型有助于更好地阐明HBV的致病机制。
- 肝炎病毒,乙型 /
- 模型,动物 /
- 小鼠,转基因 /
- 综述
Abstract: Hepatitis B virus( HBV) is a great threat to human health,but due to its strong species specificity,there are still no ideal animal models at present to clarify the pathogenesis of HBV infection. At present,the research on HBV infection models mainly concentrates on mice,and great progress has been achieved / made. This review focuses on the advantages and disadvantages of HBV transgenic mouse model,HBV- transfected mouse model,and human- mouse chimeric liver HBV mouse model,and suggests that rational application of these models helps to clarify the pathogenesis of HBV.
- hepatitis B virus /
- models,animal /
- mice,transgenic /
- review

HTML全文

参考文献(37)

[1]TREPO C,CHAN HL,LOK A.Hepatitis B virus infection[J].Lancet,2014,384(9959):2053-2063.

[2] LU FM,ZHUANG H.Management of hepatitis B in China[J].Chin Med J(Engl),2009,122(1):3-4.

[3]ALTER HJ.The unexpected outcomes of medical research:serendipity and the Australia antigen.Blumberg BS,Alter HJ,Visnich S.A new antigen in leukemia sera[J Am Med Assoc 1965,191:541-546][J].J Hepatol,2003,39(2):149-152.

[4]DUPINAY T,GHEIT T,ROQUES P,et al.Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from Mauritius Island[J].Hepatology,2013,58(5):1610-1620.

[5]BARKER LF,MAYNARD JE,PURCELL RH,et al.Hepatitis B virus infection in chimpanzees:titration of subtypes[J].J Infect Dis,1975,132(4):451-458.

[6]WANG Q,SCHWARZENBERGER P,YANG F,et al.Experimental chronic hepatitis B infection of neonatal tree shrews(Tupaia belangeri chinensis):a model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans[J].Virol J,2012,9:170.

[7]DANDRI M,LUTGEHETMANN M,PETERSEN J.Experimental models and therapeutic approaches for HBV[J].Semin Immunopathol,2013,35(1):7-21.

[8]CHISARI FV,PINKERT CA,MILICH DR,et al.A transgenic mouse model of the chronic hepatitis B surface antigen carrier state[J].Science,1985,230(4730):1157-1160.

[9]BABINET C,FARZA H,MORELLO D,et al.Specific expression of hepatitis B surface antigen(HBsA g)in transgenic mice[J].Science,1985,230(4730):1160-1163.

[10]GUIDOTTI L G,MATZKE B,SCHALLER H,et al.High-level hepatitis B virus replication in transgenic mice[J].J Virol,1995,69(10):6158-6169.

[11]WIELAND SF,SPANGENBERG HC,THIMME R,et al.Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees[J].Proc Natl Acad Sci U S A,2004,101(7):2129-2134.

[12]LARKIN J,CLAYTON M,SUN B,et al.Hepatitis B virus transgenic mouse model of chronic liver disease[J].Nat Med,1999,5(8):907-912.

[13]BARON JL,GARDINER L,NISHIMURA S,et al.Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection[J].Immunity,2002,16(4):583-594.

[14]PUBLICOVER J,GAGGAR A,NISHIMURA S,et al.Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B[J].J Clin Invest,2013,123(9):3728-3739.

[15]GOSSEN M,BUJARD H.Tight control of gene expression in mammalian cells by tetracycline-responsive promoters[J].Proc Natl Acad Sci U S A,1992,89(12):5547-5551.

[16]XU K,DENG XY,YUE Y,et al.Generation of the regulatory protein rtT A transgenic mice[J].World J Gastroenterol,2005,11(19):2885-2891.

[17]YU HM,LIU B,CHIU SY,et al.Development of a unique system for spatiotemporal and lineage-specific gene expression in mice[J].Proc Natl Acad Sci U S A,2005,102(24):8615-8620.

[18]LAN HY,ZHAO Y,YANG J,et al.Establishment of a novel triple-transgenic mouse:conditionally and liver-specifically expressing hepatitis C virus NS3/4A protease[J].Mol Biol Rep,2014,41(11):7349-7359.

[19]YANG PL,ALTHAGE A,CHUNG J,et al.Hydrodynamic injection of viral DNA:a mouse model of acute hepatitis B virus infection[J].Proc Natl Acad Sci U S A,2002,99(21):13825-13830.

[20]TAKEHARA T,SUZUKI T,OHKAWA K,et al.Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication[J].J Hepatol,2006,44(2):267-274.

[21]HUANG LR,WU HL,CHEN PJ,et al.An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection[J].Proc Natl Acad Sci U S A,2006,103(47):17862-17867.

[22]HUANG YH,FANG CC,TSUNEYAMA K,et al.A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery[J].Int J Oncol,2011,39(6):1511-1519.

[23]ILAN E,BURAKOVA T,DAGAN S,et al.The hepatitis B virus-trimera mouse:a model for human HBV infection and evaluation of anti-HBV therapeutic agents[J].Hepatology,1999,29(2):553-562.

[24]OHASHI K,MARION PL,NAKAI H,et al.Sustained survival of human hepatocytes in mice:a model for in vivo infection with human hepatitis B and hepatitis delta viruses[J].Nat Med,2000,6(3):327-331.

[25]BROWN JJ,PARASHAR B,MOSHAGE H,et al.A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice[J].Hepatology,2000,31(1):173-181.

[26]BISSIG KD,WIELAND SF,TRAN P,et al.Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment[J].J Clin Invest,2010,120(3):924-930.

[27]DANDRI M,PETERSEN J.Chimeric mouse model of hepatitis B virus infection[J].J Hepatol,2012,56(2):493-495.

[28]DANDRI M,BURDA MR,TOROK E,et al.Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus[J].Hepatology,2001,33(4):981-988.

[29]RHIM JA,SANDGREN EP,PALMITER RD,et al.Complete reconstitution of mouse liver with xenogeneic hepatocytes[J].Proc Natl Acad Sci U S A,1995,92(11):4942-4946.

[30]PETERSEN J,DANDRI M,GUPTA S,et al.Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma[J].Proc Natl Acad Sci U S A,1998,95(1):310-315.

[31]LUTGEHETMANN M,BORNSCHEUER T,VOLZ T,et al.Hepatitis B virus limits response of human hepatocytes to interferon-alpha in chimeric mice[J].Gastroenterology,2011,140(7):2074-2083.

[32]ZHOU XJ,SUN SH,WANG P,et al.Over-expression of uP A increases risk of liver injury in pA AV-HBV transfected mice[J].World J Gastroenterol,2012,18(16):1892-1902.

[33]AZUMA H,PAULK N,RANADE A,et al.Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il12rg-/-mice[J].Nat Biotechnol,2007,25(8):903-910.

[34]BILITY MT,ZHANG L,WASHBURN ML,et al.Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis[J].Nat Protoc,2012,7(9):1608-1617.

[35]WASHBURN ML,BILITY MT,ZHANG L,et al.A humanized mouse model to study hepatitis C virus infection,immune response,and liver disease[J].Gastroenterology,2011,140(4):1334-1344.

[36]BILITY MT,CHENG L,ZHANG Z,et al.Hepatitis B virus infection and immunopathogenesis in a humanized mouse model:induction of human-specific liver fibrosis and M2-like macrophages[J].PLoS Pathog,2014,10(3):e1004032.

[37]DEMBEK C,PROTZER U.Mouse models for therapeutic vaccination against hepatitis B virus[J].Med Microbiol Immunol,2015,204(1):95-102.

施引文献

资源附件(0)

访问统计